Metipranolol
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| (RS)-4-{[-2-hydroxy-3-(isopropylamino)propyl]oxy}-2,3,6-trimethylphenyl acetate | |
| Clinical data | |
| Trade names | Optipranolol |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| MedlinePlus | a601078 |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 22664-55-7 |
| ATC code | S01ED04 C07BA68 |
| PubChem | CID 31477 |
| DrugBank | APRD00668 |
| ChemSpider | 29193 |
| UNII | X39AL81KEB |
| KEGG | D02374 |
| ChEMBL | CHEMBL1291 |
| Chemical data | |
| Formula | C17H27NO4 |
| Mol. mass | 309.401 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
Metipranolol (OptiPranolol, Betanol, Disorat, Trimepranol) is a non-selective beta blocker used in eye drops to treat glaucoma. It is rapidly metabolized into desacetylmetipranolol.[1]
[edit] References
- ^ Maffei Facino, R.; Bertuletti, R.; Carini, M.; Tofanetti, O. (1980). "In vitro metabolism of methypranolol by rat liver". Analytical Chemistry Symposia Series 4 (6): 217–223.
|
| This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |

